BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1155 related articles for article (PubMed ID: 26579636)

  • 41. Prediction models of long-term cirrhosis and hepatocellular carcinoma risk in chronic hepatitis B patients: risk scores integrating host and virus profiles.
    Lee MH; Yang HI; Liu J; Batrla-Utermann R; Jen CL; Iloeje UH; Lu SN; You SL; Wang LY; Chen CJ;
    Hepatology; 2013 Aug; 58(2):546-54. PubMed ID: 23504622
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Comparison of recurrence after hepatic resection in patients with hepatitis B vs. hepatitis C-related small hepatocellular carcinoma in hepatitis B virus endemic area.
    Huang YH; Wu JC; Chen CH; Chang TT; Lee PC; Chau GY; Lui WY; Chang FY; Lee SD
    Liver Int; 2005 Apr; 25(2):236-41. PubMed ID: 15780044
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Recurrent hepatocellular carcinoma after transplantation: use of a pathological score on explanted livers to predict recurrence.
    Parfitt JR; Marotta P; Alghamdi M; Wall W; Khakhar A; Suskin NG; Quan D; McAllister V; Ghent C; Levstik M; McLean C; Chakrabarti S; Garcia B; Driman DK
    Liver Transpl; 2007 Apr; 13(4):543-51. PubMed ID: 17394152
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Development and validation of a novel predictive scoring model for microvascular invasion in patients with hepatocellular carcinoma.
    Zhao H; Hua Y; Dai T; He J; Tang M; Fu X; Mao L; Jin H; Qiu Y
    Eur J Radiol; 2017 Mar; 88():32-40. PubMed ID: 28189206
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Microvascular invasion in small hepatocellular carcinoma: is it predictable with preoperative diffusion-weighted imaging?
    Xu P; Zeng M; Liu K; Shan Y; Xu C; Lin J
    J Gastroenterol Hepatol; 2014 Feb; 29(2):330-6. PubMed ID: 24033853
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Risk factors for early recurrence of HBV-related hepatocellular carcinoma meeting milan criteria after curative resection.
    Zhu WJ; Huang CY; Li C; Peng W; Wen TF; Yan LN; Li B; Wang WT; Xu MQ; Yang JY; Jiang L
    Asian Pac J Cancer Prev; 2013; 14(12):7101-6. PubMed ID: 24460258
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Second Hepatectomy Improves Survival in Patients With Microvascular Invasive Hepatocellular Carcinoma Meeting the Milan Criteria.
    Hou YF; Li B; Wei YG; Yang JY; Wen TF; Xu MQ; Yan LV; Chen KF
    Medicine (Baltimore); 2015 Dec; 94(48):e2070. PubMed ID: 26632890
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Microvascular invasion has limited clinical values in hepatocellular carcinoma patients at Barcelona Clinic Liver Cancer (BCLC) stages 0 or B.
    Huang C; Zhu XD; Ji Y; Ding GY; Shi GM; Shen YH; Zhou J; Fan J; Sun HC
    BMC Cancer; 2017 Jan; 17(1):58. PubMed ID: 28095820
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Hepatitis B virus reactivation after radiofrequency ablation or hepatic resection for HBV-related small hepatocellular carcinoma: a retrospective study.
    Dan JQ; Zhang YJ; Huang JT; Chen MS; Gao HJ; Peng ZW; Xu L; Lau WY
    Eur J Surg Oncol; 2013 Aug; 39(8):865-72. PubMed ID: 23597497
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Comparison of surgical outcomes for hepatocellular carcinoma in patients with hepatitis B versus hepatitis C: a western experience.
    Roayaie S; Haim MB; Emre S; Fishbein TM; Sheiner PA; Miller CM; Schwartz ME
    Ann Surg Oncol; 2000 Dec; 7(10):764-70. PubMed ID: 11129425
    [TBL] [Abstract][Full Text] [Related]  

  • 51. High levels of hepatitis B surface antigen are associated with poorer survival and early recurrence of hepatocellular carcinoma in patients with low hepatitis B viral loads.
    Liu WR; Tian MX; Jin L; Yang LX; Ding ZB; Shen YH; Peng YF; Zhou J; Qiu SJ; Dai Z; Fan J; Shi YH
    Ann Surg Oncol; 2015 Mar; 22(3):843-50. PubMed ID: 25269529
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Role of hepatitis B virus infection in the prognosis after hepatectomy for hepatocellular carcinoma in patients with cirrhosis: a Western dual-center experience.
    Cescon M; Cucchetti A; Grazi GL; Ferrero A; Viganò L; Ercolani G; Ravaioli M; Zanello M; Andreone P; Capussotti L; Pinna AD
    Arch Surg; 2009 Oct; 144(10):906-13. PubMed ID: 19841357
    [TBL] [Abstract][Full Text] [Related]  

  • 53. What can we learn from hepatitis B virus clinical cohorts?
    Lin CL; Tseng TC; Kao JH
    Liver Int; 2015 Jan; 35 Suppl 1():91-9. PubMed ID: 25529093
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Nomogram predicting long-term survival after the diagnosis of intrahepatic recurrence of hepatocellular carcinoma following an initial liver resection.
    Notake T; Kobayashi A; Shinkawa H; Kawahara T; Shimizu A; Yokoyama T; Hasegawa K; Kokudo N; Matsuyama Y; Makuuchi M; Miyagawa SI
    Int J Clin Oncol; 2017 Aug; 22(4):715-725. PubMed ID: 28303401
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effects of antiviral therapy on long-term outcome after liver resection for hepatitis B virus-related hepatocellular carcinoma.
    Urata Y; Kubo S; Takemura S; Uenishi T; Kodai S; Shinkawa H; Sakae M; Kaneda K; Ohata K; Nozawa A; Suehiro S
    J Hepatobiliary Pancreat Sci; 2012 Nov; 19(6):685-96. PubMed ID: 22203455
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Investigation of histological vascular invasion from preoperative evaluation in patients with hepatocellular carcinoma who underwent living donor liver transplantation.
    Sakai K; Okajima H; Koshino K; Suzuki T; Nobori S; Matsuyama M; Ushigome H; Ochiai T; Yoshimura N
    Transplant Proc; 2012 Mar; 44(2):409-11. PubMed ID: 22410029
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Is resectable hepatocellular carcinoma a contraindication to liver transplantation? A novel decision model based on "number of patients needed to transplant" as measure of transplant benefit.
    Vitale A; Cucchetti A; Qiao GL; Cescon M; Li J; Ramirez Morales R; Frigo AC; Xia Y; Tuci F; Shen F; Cillo U; Pinna AD
    J Hepatol; 2014 Jun; 60(6):1165-71. PubMed ID: 24508550
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Microvascular infiltration has limited clinical value for treatment and prognosis in hepatocellular carcinoma.
    Portolani N; Baiocchi GL; Molfino S; Benetti A; Gheza F; Giulini SM
    World J Surg; 2014 Jul; 38(7):1769-76. PubMed ID: 24378549
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Prognostic factors for survival after hepatic resection of early hepatocellular carcinoma in HBV-related cirrhotic patients.
    Zhu Q; Yuan B; Qiao GL; Yan JJ; Li Y; Duan R; Yan YQ
    Clin Res Hepatol Gastroenterol; 2016 Sep; 40(4):418-27. PubMed ID: 26823044
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Difference in tumor invasiveness in cirrhotic patients with hepatocellular carcinoma fulfilling the Milan criteria treated by resection and transplantation: impact on long-term survival.
    Poon RT; Fan ST; Lo CM; Liu CL; Wong J
    Ann Surg; 2007 Jan; 245(1):51-8. PubMed ID: 17197965
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 58.